Characterization of a recurrent novel large duplication in the cystic fibrosis transmembrane conductance regulator gene.
Recently, DNA rearrangements in the cystic fibrosis transmembrane conductance regulator (CFTR) gene have been described with increasing frequency. These large DNA rearrangements are not detected using conventional methods of DNA sequencing, single-strand conformational polymorphism, or denaturing high-performance liquid chromatography. We and others have described methods to detect such rearrangements in the CFTR gene. With one exception, all rearrangements reported thus far are single or multiple exon deletions, whereas only one report has described a large duplication. We describe here the detection and characterization of a novel large duplication in the CFTR gene. This duplication, referred to as gIVS6a + 415_IVS10 + 2987Dup26817bp, was detected in a classic CF female patient whose other mutation was DeltaF508. The duplication was inherited paternally. The duplication encompassed exons 6b to 10 and occurred on the IVS8-11TG/IVS8-7T/G1540 haplotype. This large duplication is predicted to result in the production of a truncated CFTR protein lacking the terminal part of NBD1 domain and beyond and thus can be considered a null allele. The combination of the DeltaF508 and gIVS6a + 415_IVS10 + 2987Dup26817bp mutation probably causes the severe CF phenotype in this patient. We designed a simple polymerase chain reaction test to detect the duplication, and we further detected the same duplication from another independent laboratory. The duplication breakpoint is identical in all three patients, suggesting a likely founder mutation.
Hantash
Feras M
FM
Quest Diagnostics Nichols Institute, Molecular Genetics, 33608 Ortega Hwy, San Juan Capistrano, CA 92690, USA. feras.x.hantash@questdiagnostics.com
Redman
Joy B
JB
Goos
Dana
D
Kammesheidt
Anja
A
McGinniss
Matthew J
MJ
Sun
Weimin
W
Strom
Charles M
CM
D000328:Adult; D001483:Base Sequence; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D004252:DNA Mutational Analysis; D005091:Exons / Q000235:genetics; D005260:Female; D005453:Fluorescence; D020440:Gene Duplication; D006801:Humans; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction
D019005:Cystic Fibrosis Transmembrane Conductance Regulator
Hum Genet. 2000 Mar;106(3):259-68
10798353
Eur J Hum Genet. 2006 May;14(5):567-76
16493442
Genet Med. 2003 Jan-Feb;5(1):9-14
12544470
Hum Mutat. 2004 Apr;23(4):343-57
15024729
Clin Genet. 2004 Apr;65(4):284-7
15025720
Hum Mol Genet. 1993 Jun;2(6):677-81
7689007
Hum Genet. 1994 Jan;93(1):67-73
7505767
Hum Mol Genet. 1994 Apr;3(4):607-14
7520797
Hum Mutat. 1997;10(6):436-42
9401006
Hum Mutat. 1998;Suppl 1:S291-4
9452112
Hum Mol Genet. 1998 Apr;7(4):729-35
9499426
Hum Mutat. 1999;13(4):337
10220150
J Med Genet. 2004 Nov;41(11):e118
15520400
Hum Genet. 2005 Dec;118(3-4):331-8
16189704
Genet Med. 2006 Feb;8(2):93-5
16481891
Hum Genet. 2006 Mar;119(1-2):126-36
16362824
Clin Chem. 2000 Sep;46(9):1417-20
10973878